FULLARTON SPACE BIOTECHNOLOGIES PTY LTD

Harnessing the innovative power of space
microbiology to support life and health on Earth.
COMPANY PROFILE

COMPANY PROFILE

Humanity’s pursuit of health has never been confined to the surface of the Earth.

Fullarton Space Biotechnologies Pty Ltd is an Australian space microbiology company invested by Fullarton Group. The company focuses on space-derived microbial strain ingredient research, microecological health product development, and the commercial application of scientific research outcomes. Guided by the vision of “Exploring space biotechnology for life and health on Earth,” Fullarton Space Biotechnologies is committed to integrating aerospace technology, microbiological science, and the modern health industry to provide more forward-looking microecological health solutions for consumers and the global health sector.

In the unique environment of space, microorganisms undergo forms of selection and adaptation that differ from those on Earth. Certain strains may demonstrate enhanced activity, stability, and resilience. Based on this frontier field, the company continues to conduct research in space strain selection, ground-based screening, large-scale cultivation, functional validation, and health applications, gradually building a proprietary space microbial strain resource platform and core ingredient system.

Unlike traditional health product companies, the value of Fullarton Space Biotechnologies Pty Ltd lies not only in launching products, but also in building a complete pathway from space microbial research to health industry application. With space-derived microbial strains as its foundation, the company promotes their application in functional foods, nutritional supplements, probiotic formulations, health ingredients, and potential pharmaceutical research, responding to the market’s growing demand for innovative, effective, and safe health ingredients.

Based on this research foundation, the company has launched the SPACE ONE® Space Probiotic product series. Featuring space-screened strains as its core scientific highlight, the series combines selected probiotic strains with the prebiotic fructooligosaccharide to form a synbiotic formula — a combination of probiotics and prebiotics. The product design focuses not only on the quantity of probiotics, but also on strain survival, intestinal colonisation potential, and the synergistic effects among multiple strains. It is designed to support intestinal flora balance, digestive health, nutrient absorption, and normal immune system function.

As an Australian health technology brand serving international markets, the company places scientific innovation at its core and product safety as its foundation. SPACE ONE® Space Probiotic is manufactured in Australia and registered under the Australian TGA regulatory framework. It is also supported by GMP manufacturing standards and Halal certification, reflecting the company’s commitment to product safety, manufacturing discipline, and international quality standards.

From space-derived strains to microecological health, from research platforms to Australian manufacturing, and from innovative ingredients to everyday health products, Fullarton Space Biotechnologies Pty Ltd is transforming advanced space biotechnology into health solutions that are understandable to the market, trusted by consumers, and sustainable for the future.

Our History

SCIENCE

BALANCE
Certification
TGA
Registration
Certification
Halal
Certification
Certification
Production
License
Certification
GMP
Certification
Certification
Food Safety
Certificate
SPACEONE

Founded in Sydney, Australia, SPACE ONE® is a premium space probiotics brand. We source all raw materials from world-renowned international suppliers. All products are listed with Australia's TGA and professionally manufactured by top local Australian manufacturers with strict quality control.

2018-Present

Platform Development: Building the Foundation for Space Microbiology Research

As research continued to deepen, the company gradually established a research platform and strain resource system centred on space microorganisms, including the Space Microbial Culture Collection, FSMCC. The company continues to conduct research in strain screening, fermentation processes, microbial metabolites, and microecological health applications.

2026

Global Voyage: Expanding to International Markets From Australia to the World

SPACE ONE® officially launched in the Australian market and expanded to international markets (including China, Southeast Asia, and more). Fullarton Space Biotech is steadily evolving from a research-driven innovator into a global micro-ecological health brand. We integrate space-origin strains, synbiotic formulas, and the Australian quality system to provide consumers worldwide with more professional, reliable, and futuristic gut health solutions.

2026

Scale Production: Made in Sydney, Quality Assured Large-Scale Realization of Scientific Achievements

The product completed large-scale manufacturing at a renowned production facility in Sydney. We insist on local Australian manufacturing to ensure every capsule embodies the gene of space technology and the rigor of Australian-made standards.

2025

Quality Pinnacle: Achieving TGA Certification Stringent Standards, Authoritative Endorsement

The first SPACE ONE® Space-Grade Probiotics product successfully obtained certification from Australia's Therapeutic Goods Administration (TGA). This represents the highest recognition of our product quality and a significant milestone in our journey towards standardized, international production and market commercialization.

2025

Design & Partnership: Shaping a Future Vision Collaborating with Global Partners, Crafting the Ultimate Experience

This year, we established deep partnerships with top-tier international ingredient suppliers to ensure formula excellence and sourcing. Concurrently, our brand packaging was completed by a professional Australian design firm, perfectly blending a sense of space technology with minimalist aesthetics to deliver a premium sensory experience from the inside out.

2024

Brand Establishment: The Birth of SPACE ONE® Elevation from Technology to Brand

After years of development, we officially obtained our Australian registration and launched the SPACE ONE®​ Space-Grade Probiotics brand. This was not just the registration of a trademark but the official proclamation of our brand philosophy: "Space Technology Empowering Wellness."

2018

Technology Accumulation: Cultivating Patents & Core Achievements The Leap from Research to Application

Through sustained R&D iteration, we have developed multiple patents and technological achievements in the field of space Lactiplantibacillus plantarumand its applications. Over the past five years, we have accumulated extensive experience in strain spaceflight and ground applications, achieving substantial breakthroughs in related health fields such as selenium-enriched yeast, lactic acid bacteria fermentation, and blood glucose management. This marked our transition from pure scientific exploration to the initial stage of productization and industrialization.

2018

Scientific Genesis: Focus on Space Microbiology Company Foundation & Research Vision

The company was formally registered in Australia, established with investment from the Fullarton Group. From the outset, we defined a clear mission: to deeply focus on the scientific research, industrial incubation, and commercial application of space microbes. We explore the high activity, strong stress resistance, and vast functional potential of microorganisms formed in the unique space environment, dedicated to translating cutting-edge research into accessible nutrition, health, and gut microbiome products.